cisplatin,nivolumab
bms
['muc ,(-much)', 'nivolumab', 'cisplatin', 'urothelial', 'check,mate,274', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'cm274', 'nivo']
#gu23 cm274 phase iii demonstrates the importance of consolidating adjuvant therapy with nivolumab, but more important, to expose to neoadjuvant therapy in order to activate tumoral immunity previously. #clearmessage #importanceofneoadjuvantinmuc 
Medical oncologist and internal medicine physician at @INCancerologia interest in GU cancer and neurooncology Father of luffy 🐶🏴‍☠️